EUVIMEDEUVIMED entdecken
Crossref

Integration of Ethanol and the Immune Modulator Curcumin for Immunoablation of Hepatocellular Carcinoma

Bo Yu, Kijung Kwak, Robert J Lewandowski, Dong-Hyun Kim

Journal of Vascular and Interventional Radiology · 2024

DOI: 10.1016/j.jvir.2024.03.014 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Vascular and Interventional Radiology, 2024. Verfasst von Bo Yu und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois. Hauptthemen laut MEDLINE: Ethanol, Curcumin, Rats, Sprague-Dawley, Carcinoma, Hepatocellular. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 32 Literaturangaben. Gefördert von: NCI NIH HHS, NIBIB NIH HHS, NCI.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: To investigate immuno-ethanol ablation using an ethanol and immune adjuvant formulation as a potent immunoablation approach that can achieve an enhanced anticancer effect in the treatment of hepatocellular carcinoma (HCC). MATERIALS AND METHODS: Ethanol concentration- and exposure time-dependent cellular responses were investigated. Curcumin was combined with ethanol as an immunoablation agent. Cellular uptake of curcumin, cancer cell killing, and inflammatory markers of ethanol-curcumin treatment were characterized. To evaluate the potential in vivo anticancer immunity of ethanol-curcumin treatment, each right and left lobe of rat liver was concurrently inoculated with N1S1 HCC cells and a mixture of treated N1S1 cells (ethanol only or ethanol-curcumin) in Sprague Dawley rats (each group: 5 rats; control: nontreated N1S1 cells). Tumor growth and immune response were characterized with 7T magnetic resonance (MR) imaging, flow cytometry analysis, and immunohistology. RESULTS: An optimized ethanol-curcumin (10% ethanol and 0.5% weight/volume (w/v) curcumin solution) treatment contributed to an enhanced cellular uptake of curcumin, increased cancer cell killing, and decreased inflammatory reaction. Ethanol-curcumin-treated N1S1 cell implantation in the rat liver demonstrated N1S1 HCC tumor rejection. The secondary tumor growth by nontreated N1S1 cell inoculation was significantly suppressed at the same time. Activated anticancer immunity was evidenced by significantly increased CD8+ T cell infiltration (3.5-fold) and CD8+-to-regulatory T cell ratio (4.5-fold) in the experimental group compared with those in the control group. CONCLUSIONS: Enhanced anticancer effect of immuno-ethanol ablation could be achieved with ethanol-curcumin agent. The results underscore the importance of optimized immunoablation therapeutic procedures for enhanced therapeutic outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

EthanolCurcuminRats, Sprague-DawleyCarcinoma, HepatocellularAnimalsCell Line, TumorRatsLiver NeoplasmsMaleAblation TechniquesAntineoplastic AgentsLiver Neoplasms, ExperimentalImmunotherapyDose-Response Relationship, DrugTumor BurdenTime Factors

Substanzen

EthanolCurcuminAntineoplastic Agents

Autor:innen und Institutionen

  • Department of Radiology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois.
  • Department of Radiology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois; Robert H. Lurie Comprehensive Cancer Center, Chicago, Illinois; Department of Biomedical Engineering, McCormick School of…

Förderung

  • NCI NIH HHS
  • NIBIB NIH HHS
  • NCI
  • NIBIB

Zitieren

APA

Yu, B., Kwak, K., Lewandowski, R. J., & Kim, D. H. (2024). Integration of Ethanol and the Immune Modulator Curcumin for Immunoablation of Hepatocellular Carcinoma. Journal of Vascular and Interventional Radiology. https://doi.org/10.1016/j.jvir.2024.03.014

Vancouver

Yu B, Kwak K, Lewandowski RJ, Kim DH. Integration of Ethanol and the Immune Modulator Curcumin for Immunoablation of Hepatocellular Carcinoma. Journal of Vascular and Interventional Radiology. 2024. doi:10.1016/j.jvir.2024.03.014

BibTeX
@article{Yu2024,
  author = {Yu, Bo and Kwak, Kijung and Lewandowski, Robert J and Kim, Dong-Hyun},
  title = {Integration of Ethanol and the Immune Modulator Curcumin for Immunoablation of Hepatocellular Carcinoma},
  journal = {Journal of Vascular and Interventional Radiology},
  year = {2024},
  doi = {10.1016/j.jvir.2024.03.014}
}
Kostenlos starten →